Publications by authors named "Jose Velarde"

Claim this Profile
I
Inflammation awakens dormant cancer cells by modulating the epithelial-mesenchymal phenotypic state.
Jingwei Zhang, Jingwen Zhang, Longfei Han, Shiyi Wu, Jie Li, Jose Velarde

Proc Natl Acad Sci U S A· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unbiased discovery of antibody therapies that stimulate macrophage-mediated destruction of B-cell lymphoma.
Juliano Ribeiro, Carlota Pagès-Geli, Anna Meglan, Jose Velarde, Jasmine Blandin

bioRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD47 predominates over CD24 as a macrophage immune checkpoint in cancer.
Juliet Allen, Anna Meglan, Kyle Vaccaro, José Velarde, Victor Chen

bioRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastoma.
Elie Massaad, William J Smith, Joseph Bradley, Eric Esposito, Mihir Gupta, José K Velarde

Neuro Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.
Kyle Vaccaro, Juliet Allen, Troy W Whitfield, Asaf Maoz, Sarah Reeves, José Velarde

J Clin Invest· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.
Kyle Vaccaro, Juliet Allen, Troy W Whitfield, Asaf Maoz, Sarah Reeves, José Velarde

bioRxiv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rapid genotyping panel for detection of primary central nervous system lymphoma.
Mihir Gupta, Evan J Burns, Nicholas Z Georgantas, Julia Thierauf, Naema Nayyar, Jose Velarde

Blood· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution.
Sofia España, Alejandra Pérez Montes de Oca, Montserrat Marques-Pamies, Marc Cucurull, Marta Domenech, José María Velarde

Transl Lung Cancer Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of stem cell markers in glioblastoma.
Francesc Alameda, José María Velarde, Cristina Carrato, Noemí Vidal, Montserrat Arumí

Biomarkers· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data on T-DM1 efficacy - results of a single-center retrospective study of HER2-positive breast cancer patients.
Max Hardy-Werbin, Vanesa Quiroga, Beatriz Cirauqui, Margarita Romeo, Eudald Felip, Jose Maria Velarde

Sci Rep· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer.
Teresa Moran, Vanesa Quiroga, Beatriz Cirauqui, Laia Vila, Maria Gil-Moreno, Jose Maria Velarde

Oncol Res Treat· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients.
Anna Estival, Carolina Sanz, Jose-Luis Ramirez, Jose Maria Velarde, Marta Domenech

Sci Rep· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Monitoring -T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer.
Teresa Morán, Eudald Felip, Joaquim Bosch-Barrera, Itziar de Aguirre, Jose Luis Ramirez, Jose María Velarde

Oncotarget· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring -T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer.
Teresa Morán, Eudald Felip, Joaquim Bosch-Barrera, Itziar de Aguirre, Jose Luis Ramirez, Jose María Velarde

Oncotarget· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study.
Jaume Capellades, Josep Puig, Sira Domenech, Teresa Pujol, Laura Oleaga, Jose Maria Velarde

J Neurooncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incomplete flap with characteristics similar to corneal ectasia.
Jose I Velarde, Jose Fernandez Cotero

J Cataract Refract Surg· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pulmonary vein ablation in atrial fibrillation. Initial experience].
José Luis Velarde, Ricardo Martellotto, Mauricio Scanavacca, Aldo Arévalo, Roberto Colque

Rev Esp Cardiol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis